HAVCR2 and cancer: The analysis of immune checkpoint genes revealed a significant correlation between LY6H expression and multiple key immune checkpoint genes across various cancer types (Figure 8B), including PD-1, PD-L1, CTLA-4, LAG-3, TIGIT, BTLA, TIM-3, AA2R, CEACAM1, SIRP-α, and CD200R.